Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• S&P shares jump report of potential CapIQ spinout
• Energy Vault’s 100 MW AI Infrastructure Project in Sardinia Receives Italian Government Designation as Project of Pre-Eminent National Strategic Interest
• Trump: striking Iranian targets near Strait of Hormuz